Handl Therapeutics

Handl Therapeutics is a biotechnology company based in Leuven, Belgium, focused on developing in vivo gene therapies for complex neurodegenerative diseases. Founded in 2019, the company aims to address significant unmet medical needs through its innovative therapeutics platform, which is designed to deliver advanced medicines to the market. By leveraging its expertise in gene therapy, Handl Therapeutics seeks to provide transformative treatment options for patients suffering from challenging neurological conditions.